

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinization (GO:0031424) | 7.95083827 |
| 2 | desmosome organization (GO:0002934) | 7.63435290 |
| 3 | drug transmembrane transport (GO:0006855) | 6.39558885 |
| 4 | hemidesmosome assembly (GO:0031581) | 6.25529090 |
| 5 | central nervous system myelination (GO:0022010) | 6.17821200 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 6.17821200 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.79122632 |
| 8 | establishment of skin barrier (GO:0061436) | 5.75383386 |
| 9 | urate metabolic process (GO:0046415) | 5.59607219 |
| 10 | response to mercury ion (GO:0046689) | 5.40889866 |
| 11 | regulation of water loss via skin (GO:0033561) | 5.40588071 |
| 12 | drug transport (GO:0015893) | 5.21790124 |
| 13 | phosphate ion transport (GO:0006817) | 4.95410164 |
| 14 | organic cation transport (GO:0015695) | 4.88248901 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.70884839 |
| 16 | surfactant homeostasis (GO:0043129) | 4.49360457 |
| 17 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.35023510 |
| 18 | keratinocyte differentiation (GO:0030216) | 4.25130413 |
| 19 | excretion (GO:0007588) | 4.23150535 |
| 20 | quaternary ammonium group transport (GO:0015697) | 4.16045912 |
| 21 | peptide cross-linking (GO:0018149) | 4.15962374 |
| 22 | lysine catabolic process (GO:0006554) | 4.11630860 |
| 23 | lysine metabolic process (GO:0006553) | 4.11630860 |
| 24 | glutathione biosynthetic process (GO:0006750) | 4.09405940 |
| 25 | endothelial cell chemotaxis (GO:0035767) | 4.05346200 |
| 26 | multicellular organismal water homeostasis (GO:0050891) | 4.04885588 |
| 27 | phosphate ion transmembrane transport (GO:0035435) | 3.99326685 |
| 28 | metanephric tubule development (GO:0072170) | 3.95006767 |
| 29 | metanephric nephron tubule development (GO:0072234) | 3.95006767 |
| 30 | skin morphogenesis (GO:0043589) | 3.92558277 |
| 31 | keratinocyte proliferation (GO:0043616) | 3.89973823 |
| 32 | L-phenylalanine catabolic process (GO:0006559) | 3.86303510 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.86303510 |
| 34 | creatine metabolic process (GO:0006600) | 3.81249855 |
| 35 | aspartate family amino acid catabolic process (GO:0009068) | 3.73270917 |
| 36 | glyoxylate metabolic process (GO:0046487) | 3.71515168 |
| 37 | vitamin D metabolic process (GO:0042359) | 3.69580601 |
| 38 | metanephric nephron epithelium development (GO:0072243) | 3.69469187 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69361505 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 3.69361505 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 3.67767904 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 3.67684935 |
| 43 | chemical homeostasis within a tissue (GO:0048875) | 3.63179127 |
| 44 | peptide biosynthetic process (GO:0043043) | 3.62677549 |
| 45 | phosphate ion homeostasis (GO:0055062) | 3.61048700 |
| 46 | trivalent inorganic anion homeostasis (GO:0072506) | 3.61048700 |
| 47 | renal absorption (GO:0070293) | 3.59422744 |
| 48 | peptidyl-proline hydroxylation (GO:0019511) | 3.58036620 |
| 49 | ensheathment of neurons (GO:0007272) | 3.53320574 |
| 50 | axon ensheathment (GO:0008366) | 3.53320574 |
| 51 | fatty acid elongation (GO:0030497) | 3.52729485 |
| 52 | polyol transport (GO:0015791) | 3.51075463 |
| 53 | intermediate filament organization (GO:0045109) | 3.50116188 |
| 54 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.48992840 |
| 55 | protein localization to endosome (GO:0036010) | 3.47504991 |
| 56 | water homeostasis (GO:0030104) | 3.43999110 |
| 57 | hair cycle (GO:0042633) | 3.43005614 |
| 58 | molting cycle (GO:0042303) | 3.43005614 |
| 59 | myelination (GO:0042552) | 3.40761239 |
| 60 | drug catabolic process (GO:0042737) | 3.39223507 |
| 61 | cell-substrate junction assembly (GO:0007044) | 3.38605741 |
| 62 | metanephric epithelium development (GO:0072207) | 3.36020760 |
| 63 | cysteine metabolic process (GO:0006534) | 3.33302176 |
| 64 | epidermal cell differentiation (GO:0009913) | 3.30355865 |
| 65 | toxin transport (GO:1901998) | 3.27534085 |
| 66 | tricarboxylic acid metabolic process (GO:0072350) | 3.26600194 |
| 67 | exogenous drug catabolic process (GO:0042738) | 3.26281999 |
| 68 | * myelin maintenance (GO:0043217) | 3.24429575 |
| 69 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22473714 |
| 70 | response to lead ion (GO:0010288) | 3.16915565 |
| 71 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.16353456 |
| 72 | COPI coating of Golgi vesicle (GO:0048205) | 3.13111099 |
| 73 | Golgi transport vesicle coating (GO:0048200) | 3.13111099 |
| 74 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.12960949 |
| 75 | nephron tubule development (GO:0072080) | 3.08779265 |
| 76 | photoreceptor cell differentiation (GO:0046530) | 3.06696177 |
| 77 | eye photoreceptor cell differentiation (GO:0001754) | 3.06696177 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 3.05549731 |
| 79 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.04578580 |
| 80 | epidermis development (GO:0008544) | 3.04180891 |
| 81 | protein retention in ER lumen (GO:0006621) | 3.02464812 |
| 82 | protein hydroxylation (GO:0018126) | 2.98401496 |
| 83 | sodium-independent organic anion transport (GO:0043252) | 2.93426138 |
| 84 | modified amino acid transport (GO:0072337) | 2.92201430 |
| 85 | 4-hydroxyproline metabolic process (GO:0019471) | 2.90899314 |
| 86 | response to methylmercury (GO:0051597) | 2.86814850 |
| 87 | carnitine transport (GO:0015879) | 2.84393808 |
| 88 | amino-acid betaine transport (GO:0015838) | 2.84393808 |
| 89 | glucose 6-phosphate metabolic process (GO:0051156) | 2.84310374 |
| 90 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.84262955 |
| 91 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.82642151 |
| 92 | response to phenylpropanoid (GO:0080184) | 2.81649228 |
| 93 | glutathione derivative biosynthetic process (GO:1901687) | 2.80752036 |
| 94 | glutathione derivative metabolic process (GO:1901685) | 2.80752036 |
| 95 | very long-chain fatty acid metabolic process (GO:0000038) | 2.80640079 |
| 96 | neuron remodeling (GO:0016322) | 2.79139474 |
| 97 | detection of bacterium (GO:0016045) | 2.76947941 |
| 98 | cellular response to vitamin D (GO:0071305) | 2.76183794 |
| 99 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.75735130 |
| 100 | glycoside metabolic process (GO:0016137) | 2.74221513 |
| 101 | gap junction assembly (GO:0016264) | 2.73528334 |
| 102 | renal tubule development (GO:0061326) | 2.72066755 |
| 103 | aromatic amino acid family catabolic process (GO:0009074) | 2.72022974 |
| 104 | glutathione metabolic process (GO:0006749) | 2.69859019 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 2.67710694 |
| 106 | hypotonic response (GO:0006971) | 2.66142009 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.62775533 |
| 108 | positive regulation of p38MAPK cascade (GO:1900745) | 2.61506391 |
| 109 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.60632463 |
| 110 | positive regulation of epidermis development (GO:0045684) | 2.60219034 |
| 111 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59481801 |
| 112 | nephron epithelium development (GO:0072009) | 2.57166345 |
| 113 | detection of other organism (GO:0098543) | 2.55873028 |
| 114 | import into cell (GO:0098657) | 2.54959469 |
| 115 | fatty acid beta-oxidation (GO:0006635) | 2.53494370 |
| 116 | sodium ion transport (GO:0006814) | 2.53359623 |
| 117 | branched-chain amino acid catabolic process (GO:0009083) | 2.52031155 |
| 118 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50772658 |
| 119 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49571595 |
| 120 | barbed-end actin filament capping (GO:0051016) | 2.49304518 |
| 121 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.48771763 |
| 122 | dopamine biosynthetic process (GO:0042416) | 2.48435942 |
| 123 | L-amino acid import (GO:0043092) | 2.47577175 |
| 124 | epithelial cell-cell adhesion (GO:0090136) | 2.46479000 |
| 125 | angiotensin maturation (GO:0002003) | 2.46437034 |
| 126 | sodium ion export (GO:0071436) | 2.45903433 |
| 127 | cellular potassium ion homeostasis (GO:0030007) | 2.45845341 |
| 128 | valine metabolic process (GO:0006573) | 2.44924647 |
| 129 | low-density lipoprotein particle clearance (GO:0034383) | 2.43894104 |
| 130 | proline metabolic process (GO:0006560) | 2.42883412 |
| 131 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.42560001 |
| 132 | magnesium ion transport (GO:0015693) | 2.41419497 |
| 133 | regulation of p38MAPK cascade (GO:1900744) | 2.40159746 |
| 134 | fructose metabolic process (GO:0006000) | 2.37494724 |
| 135 | cell adhesion mediated by integrin (GO:0033627) | 2.36320350 |
| 136 | nephron tubule formation (GO:0072079) | 2.35979066 |
| 137 | fatty acid oxidation (GO:0019395) | 2.35529509 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.35261534 |
| 139 | potassium ion import (GO:0010107) | 2.35261342 |
| 140 | intermediate filament cytoskeleton organization (GO:0045104) | 2.35243344 |
| 141 | regulation of lipoprotein metabolic process (GO:0050746) | 2.34959255 |
| 142 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.34161977 |
| 143 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.33865409 |
| 144 | amyloid precursor protein metabolic process (GO:0042982) | 2.33725588 |
| 145 | response to growth hormone (GO:0060416) | 2.33722575 |
| 146 | adhesion of symbiont to host (GO:0044406) | 2.33462373 |
| 147 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.33006511 |
| 148 | cobalamin metabolic process (GO:0009235) | 2.32755844 |
| 149 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32671073 |
| 150 | glycine transport (GO:0015816) | 2.32479986 |
| 151 | apical protein localization (GO:0045176) | 2.32435033 |
| 152 | heme transport (GO:0015886) | 2.32379158 |
| 153 | linoleic acid metabolic process (GO:0043651) | 2.31726053 |
| 154 | lipoxygenase pathway (GO:0019372) | 2.31689579 |
| 155 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.30343902 |
| 156 | oligosaccharide catabolic process (GO:0009313) | 2.30336043 |
| 157 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.30234430 |
| 158 | lipid oxidation (GO:0034440) | 2.30199465 |
| 159 | response to lipoprotein particle (GO:0055094) | 2.28874790 |
| 160 | glutamate metabolic process (GO:0006536) | 2.28710688 |
| 161 | fatty acid catabolic process (GO:0009062) | 2.28607002 |
| 162 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.28439680 |
| 163 | cellular response to vitamin (GO:0071295) | 2.27713900 |
| 164 | pinocytosis (GO:0006907) | 2.26076279 |
| 165 | basement membrane organization (GO:0071711) | 2.25293549 |
| 166 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24078585 |
| 167 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.23506343 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 2.23285731 |
| 169 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.22743347 |
| 170 | intermediate filament-based process (GO:0045103) | 2.21587865 |
| 171 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.19282505 |
| 172 | cell-cell junction maintenance (GO:0045217) | 2.18493278 |
| 173 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.17639354 |
| 174 | response to laminar fluid shear stress (GO:0034616) | 2.17388049 |
| 175 | cell volume homeostasis (GO:0006884) | 2.15409997 |
| 176 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.14797804 |
| 177 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.13628030 |
| 178 | embryonic process involved in female pregnancy (GO:0060136) | 2.12566315 |
| 179 | endocytic recycling (GO:0032456) | 2.10704280 |
| 180 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.10446190 |
| 181 | activation of Rac GTPase activity (GO:0032863) | 2.10060707 |
| 182 | protein-lipid complex assembly (GO:0065005) | 2.09790567 |
| 183 | virion attachment to host cell (GO:0019062) | 2.09395289 |
| 184 | adhesion of symbiont to host cell (GO:0044650) | 2.09395289 |
| 185 | cell communication involved in cardiac conduction (GO:0086065) | 2.09182082 |
| 186 | regulation of keratinocyte differentiation (GO:0045616) | 2.06305721 |
| 187 | renal filtration (GO:0097205) | 2.05664673 |
| 188 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.05050265 |
| 189 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.04523947 |
| 190 | regulation of extracellular matrix organization (GO:1903053) | 2.03364947 |
| 191 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.03269564 |
| 192 | lung vasculature development (GO:0060426) | 2.01822154 |
| 193 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.00446823 |
| 194 | focal adhesion assembly (GO:0048041) | 1.99546792 |
| 195 | cell-substrate adherens junction assembly (GO:0007045) | 1.99546792 |
| 196 | positive regulation of extracellular matrix organization (GO:1903055) | 1.99509883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.66254045 |
| 2 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48084190 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.42325808 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31692871 |
| 5 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.26993482 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.06886215 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97149091 |
| 8 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94628354 |
| 9 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89000238 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78419728 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.77126948 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75553453 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.75533697 |
| 14 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75265810 |
| 15 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73514318 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71424552 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70911699 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68051774 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65207048 |
| 20 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.64780050 |
| 21 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.64780050 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64768637 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63792947 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63264134 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58109431 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53262822 |
| 27 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53137786 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52599395 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52599395 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52413893 |
| 31 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48702015 |
| 32 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48042120 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47882756 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45469217 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44660041 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43968663 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43467553 |
| 38 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43396078 |
| 39 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42246006 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42137576 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41731965 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.41610909 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40614653 |
| 44 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38988070 |
| 45 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.38618409 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37366626 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35994701 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35771316 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35371177 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33684512 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33301865 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32514885 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32015260 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31080699 |
| 55 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30229956 |
| 56 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28917743 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27836529 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27734203 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27040706 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26078646 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25840533 |
| 62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25741889 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25714459 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24926884 |
| 65 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.23173290 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22912264 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22735169 |
| 68 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20253988 |
| 69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19901088 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19324191 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19324191 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17907784 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17743972 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15698391 |
| 75 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.15423794 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14629308 |
| 77 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14313224 |
| 78 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13896529 |
| 79 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13392521 |
| 80 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12800061 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10784509 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10124479 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09902337 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08499116 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08368940 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08098226 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07749785 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07730498 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06982248 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05844138 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05375735 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05153847 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05151098 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04657389 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03277824 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03035717 |
| 97 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02283799 |
| 98 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02144646 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01036649 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00765392 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99749786 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99571494 |
| 103 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98845965 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97979041 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97142122 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96652535 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95996088 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 0.94592833 |
| 109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94424009 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94311912 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94115304 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93959203 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93389976 |
| 114 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93190850 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93044008 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92776743 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92188815 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91660960 |
| 119 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90649368 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90620581 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90620581 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90365491 |
| 123 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90323080 |
| 124 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90270219 |
| 125 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89232443 |
| 126 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88905663 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88647187 |
| 128 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88197828 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87120360 |
| 130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87019047 |
| 131 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86948185 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86771969 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86734628 |
| 134 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86678580 |
| 135 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86662151 |
| 136 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86384145 |
| 137 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86254754 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86117571 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85816419 |
| 140 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85762372 |
| 141 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84257594 |
| 142 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83872589 |
| 143 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83069577 |
| 144 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83042175 |
| 145 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82962561 |
| 146 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82889659 |
| 147 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81906909 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81309367 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80590736 |
| 150 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80215369 |
| 151 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77742134 |
| 152 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76353222 |
| 153 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76294641 |
| 154 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75248888 |
| 155 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.74915592 |
| 156 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74250702 |
| 157 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74144751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.10145591 |
| 2 | MP0005360_urolithiasis | 4.51053746 |
| 3 | MP0000579_abnormal_nail_morphology | 4.08456905 |
| 4 | MP0003195_calcinosis | 4.06012282 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.58371180 |
| 6 | MP0005275_abnormal_skin_tensile | 3.58169221 |
| 7 | MP0001765_abnormal_ion_homeostasis | 3.41403846 |
| 8 | MP0005332_abnormal_amino_acid | 3.38757342 |
| 9 | MP0004885_abnormal_endolymph | 3.12957761 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 3.10860937 |
| 11 | MP0003566_abnormal_cell_adhesion | 3.07532624 |
| 12 | * MP0000920_abnormal_myelination | 3.05514455 |
| 13 | MP0003453_abnormal_keratinocyte_physiol | 3.03726667 |
| 14 | MP0009643_abnormal_urine_homeostasis | 2.96035272 |
| 15 | MP0001756_abnormal_urination | 2.46621672 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.37356266 |
| 17 | MP0001216_abnormal_epidermal_layer | 2.37096788 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.32050145 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.31193196 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.30139447 |
| 21 | MP0000467_abnormal_esophagus_morphology | 2.28312184 |
| 22 | MP0002060_abnormal_skin_morphology | 2.26075116 |
| 23 | MP0001958_emphysema | 2.24983090 |
| 24 | MP0003329_amyloid_beta_deposits | 2.15448211 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 2.14890062 |
| 26 | MP0005023_abnormal_wound_healing | 2.12704013 |
| 27 | MP0002136_abnormal_kidney_physiology | 2.08178319 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 2.06799523 |
| 29 | MP0000566_synostosis | 1.93269875 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.92698921 |
| 31 | MP0004947_skin_inflammation | 1.90868921 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.84937712 |
| 33 | MP0003878_abnormal_ear_physiology | 1.84937712 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.81296707 |
| 35 | MP0003690_abnormal_glial_cell | 1.80315147 |
| 36 | MP0003941_abnormal_skin_development | 1.70509957 |
| 37 | MP0010771_integument_phenotype | 1.70312064 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.65681474 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.65439258 |
| 40 | MP0004742_abnormal_vestibular_system | 1.64929752 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.64814145 |
| 42 | MP0004270_analgesia | 1.58879238 |
| 43 | MP0003634_abnormal_glial_cell | 1.51975024 |
| 44 | MP0004381_abnormal_hair_follicle | 1.49279992 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.39092783 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.37369562 |
| 47 | MP0000747_muscle_weakness | 1.36370299 |
| 48 | MP0000377_abnormal_hair_follicle | 1.34745999 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32252272 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.27850194 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.26080617 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25078839 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.24933869 |
| 54 | MP0002229_neurodegeneration | 1.24737239 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.23364813 |
| 56 | MP0001851_eye_inflammation | 1.22267300 |
| 57 | MP0002796_impaired_skin_barrier | 1.21800079 |
| 58 | MP0004272_abnormal_basement_membrane | 1.21350327 |
| 59 | MP0009931_abnormal_skin_appearance | 1.21237499 |
| 60 | MP0004147_increased_porphyrin_level | 1.20576931 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.16570853 |
| 62 | MP0004510_myositis | 1.16219900 |
| 63 | MP0003879_abnormal_hair_cell | 1.15832251 |
| 64 | MP0002896_abnormal_bone_mineralization | 1.15689432 |
| 65 | MP0003091_abnormal_cell_migration | 1.15195848 |
| 66 | MP0003252_abnormal_bile_duct | 1.14836443 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.14090190 |
| 68 | MP0000604_amyloidosis | 1.13890046 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.12462410 |
| 70 | MP0001849_ear_inflammation | 1.11810089 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.11771750 |
| 72 | MP0003315_abnormal_perineum_morphology | 1.09875689 |
| 73 | MP0005451_abnormal_body_composition | 1.08919625 |
| 74 | MP0010678_abnormal_skin_adnexa | 1.08776041 |
| 75 | MP0003186_abnormal_redox_activity | 1.07447638 |
| 76 | MP0002168_other_aberrant_phenotype | 1.05177567 |
| 77 | MP0003283_abnormal_digestive_organ | 1.04411091 |
| 78 | MP0009053_abnormal_anal_canal | 1.03545075 |
| 79 | MP0002272_abnormal_nervous_system | 1.01136894 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 1.00424363 |
| 81 | MP0009379_abnormal_foot_pigmentation | 0.98752306 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.97302713 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.96834394 |
| 84 | MP0003436_decreased_susceptibility_to | 0.96364866 |
| 85 | MP0001666_abnormal_nutrient_absorption | 0.95404398 |
| 86 | MP0005171_absent_coat_pigmentation | 0.95273419 |
| 87 | MP0000462_abnormal_digestive_system | 0.94107786 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.94011555 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.93783673 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.91960329 |
| 91 | MP0004858_abnormal_nervous_system | 0.89377599 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.87788693 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.87482516 |
| 94 | MP0002064_seizures | 0.85519359 |
| 95 | MP0005365_abnormal_bile_salt | 0.84977510 |
| 96 | * MP0003633_abnormal_nervous_system | 0.84814946 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.83371272 |
| 98 | MP0001661_extended_life_span | 0.82986262 |
| 99 | MP0000858_altered_metastatic_potential | 0.82132241 |
| 100 | MP0000367_abnormal_coat/_hair | 0.82032886 |
| 101 | MP0005166_decreased_susceptibility_to | 0.81602778 |
| 102 | MP0003632_abnormal_nervous_system | 0.81242118 |
| 103 | MP0001486_abnormal_startle_reflex | 0.81021621 |
| 104 | MP0005535_abnormal_body_temperature | 0.80877695 |
| 105 | MP0009840_abnormal_foam_cell | 0.79080398 |
| 106 | MP0003959_abnormal_lean_body | 0.78720925 |
| 107 | MP0005501_abnormal_skin_physiology | 0.77522529 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 0.77433974 |
| 109 | MP0005408_hypopigmentation | 0.77239296 |
| 110 | * MP0003631_nervous_system_phenotype | 0.77238288 |
| 111 | MP0005165_increased_susceptibility_to | 0.77005887 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.76742710 |
| 113 | MP0004142_abnormal_muscle_tone | 0.76228471 |
| 114 | MP0001664_abnormal_digestion | 0.75285852 |
| 115 | MP0001191_abnormal_skin_condition | 0.75018349 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.74739189 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.74696098 |
| 118 | MP0002006_tumorigenesis | 0.74555120 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.74121129 |
| 120 | MP0003011_delayed_dark_adaptation | 0.73903754 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.73464535 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.72838381 |
| 123 | MP0008260_abnormal_autophagy | 0.72505340 |
| 124 | MP0003303_peritoneal_inflammation | 0.72119017 |
| 125 | MP0003045_fibrosis | 0.71471663 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.71024211 |
| 127 | MP0005164_abnormal_response_to | 0.70739673 |
| 128 | MP0003075_altered_response_to | 0.69229727 |
| 129 | MP0000762_abnormal_tongue_morphology | 0.69199379 |
| 130 | MP0000627_abnormal_mammary_gland | 0.67784723 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.66496824 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.65640263 |
| 133 | MP0005195_abnormal_posterior_eye | 0.65579847 |
| 134 | MP0006072_abnormal_retinal_apoptosis | 0.64812315 |
| 135 | MP0000778_abnormal_nervous_system | 0.64470107 |
| 136 | MP0005085_abnormal_gallbladder_physiolo | 0.63775704 |
| 137 | MP0010386_abnormal_urinary_bladder | 0.63412799 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.63202424 |
| 139 | MP0002971_abnormal_brown_adipose | 0.62838935 |
| 140 | MP0005253_abnormal_eye_physiology | 0.61945334 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.61443960 |
| 142 | MP0001177_atelectasis | 0.61437617 |
| 143 | MP0001533_abnormal_skeleton_physiology | 0.61266801 |
| 144 | MP0001299_abnormal_eye_distance/ | 0.60732555 |
| 145 | MP0005670_abnormal_white_adipose | 0.60264074 |
| 146 | MP0010329_abnormal_lipoprotein_level | 0.58862777 |
| 147 | MP0008004_abnormal_stomach_pH | 0.58323018 |
| 148 | MP0005409_darkened_coat_color | 0.58073969 |
| 149 | MP0000383_abnormal_hair_follicle | 0.57511302 |
| 150 | MP0005623_abnormal_meninges_morphology | 0.57117160 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.56754765 |
| 152 | MP0005381_digestive/alimentary_phenotyp | 0.56141350 |
| 153 | MP0006138_congestive_heart_failure | 0.55745591 |
| 154 | MP0002909_abnormal_adrenal_gland | 0.53233089 |
| 155 | MP0003279_aneurysm | 0.52512794 |
| 156 | MP0010368_abnormal_lymphatic_system | 0.52333213 |
| 157 | MP0003868_abnormal_feces_composition | 0.52290384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.65173175 |
| 2 | Abnormality of nail color (HP:0100643) | 7.64198245 |
| 3 | Metabolic alkalosis (HP:0200114) | 7.22817239 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 7.08603372 |
| 5 | Hypomagnesemia (HP:0002917) | 6.68529393 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.78507821 |
| 7 | Polyuria (HP:0000103) | 5.70007656 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 5.65219858 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 5.46838773 |
| 10 | Abnormal urine output (HP:0012590) | 5.31166457 |
| 11 | Thick nail (HP:0001805) | 5.27436755 |
| 12 | Gout (HP:0001997) | 5.23905479 |
| 13 | Abnormality of renal excretion (HP:0011036) | 5.12304647 |
| 14 | Palmoplantar hyperkeratosis (HP:0000972) | 5.07750577 |
| 15 | Alopecia of scalp (HP:0002293) | 4.92080107 |
| 16 | Plantar hyperkeratosis (HP:0007556) | 4.85404488 |
| 17 | Abnormal drinking behavior (HP:0030082) | 4.71954642 |
| 18 | Polydipsia (HP:0001959) | 4.71954642 |
| 19 | Palmar hyperkeratosis (HP:0010765) | 4.70169915 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 4.58998049 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 4.53536621 |
| 22 | Renal salt wasting (HP:0000127) | 4.50620221 |
| 23 | Hyperaldosteronism (HP:0000859) | 4.33992886 |
| 24 | Alkalosis (HP:0001948) | 4.24999724 |
| 25 | Tetany (HP:0001281) | 4.18118973 |
| 26 | Proximal tubulopathy (HP:0000114) | 3.81227397 |
| 27 | Onycholysis (HP:0001806) | 3.69230536 |
| 28 | Milia (HP:0001056) | 3.67589903 |
| 29 | Increased purine levels (HP:0004368) | 3.65110487 |
| 30 | Hyperuricemia (HP:0002149) | 3.65110487 |
| 31 | Hypokalemia (HP:0002900) | 3.60971110 |
| 32 | Oral leukoplakia (HP:0002745) | 3.59684061 |
| 33 | Hypercalciuria (HP:0002150) | 3.52530886 |
| 34 | Increased IgE level (HP:0003212) | 3.30072228 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29153613 |
| 36 | Abnormal blistering of the skin (HP:0008066) | 3.20403670 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.17974610 |
| 38 | Nail dystrophy (HP:0008404) | 3.16649887 |
| 39 | Follicular hyperkeratosis (HP:0007502) | 3.09577448 |
| 40 | Abnormality of potassium homeostasis (HP:0011042) | 3.05078860 |
| 41 | Fragile nails (HP:0001808) | 2.99667164 |
| 42 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.97013020 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.93282131 |
| 44 | Natal tooth (HP:0000695) | 2.87333783 |
| 45 | Erythema (HP:0010783) | 2.86580585 |
| 46 | Hyperglycinuria (HP:0003108) | 2.84819216 |
| 47 | Delayed epiphyseal ossification (HP:0002663) | 2.81018370 |
| 48 | Ketoacidosis (HP:0001993) | 2.80531773 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.78769891 |
| 50 | Atrophic scars (HP:0001075) | 2.78309469 |
| 51 | Advanced eruption of teeth (HP:0006288) | 2.78247977 |
| 52 | Hypotrichosis (HP:0001006) | 2.77779894 |
| 53 | Flat acetabular roof (HP:0003180) | 2.76960000 |
| 54 | Lip pit (HP:0100267) | 2.72712861 |
| 55 | Corneal erosion (HP:0200020) | 2.70991629 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70306724 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.70306724 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.63256469 |
| 59 | Glycosuria (HP:0003076) | 2.63256469 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.62385293 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.62385293 |
| 62 | Abnormality of the axillary hair (HP:0100134) | 2.59337645 |
| 63 | Abnormality of secondary sexual hair (HP:0009888) | 2.59337645 |
| 64 | Renal tubular acidosis (HP:0001947) | 2.56574912 |
| 65 | Malnutrition (HP:0004395) | 2.54969052 |
| 66 | Nephrocalcinosis (HP:0000121) | 2.50241110 |
| 67 | Abnormality of the salivary glands (HP:0010286) | 2.47814253 |
| 68 | Rickets (HP:0002748) | 2.47021640 |
| 69 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.40380198 |
| 70 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.40380198 |
| 71 | Vascular calcification (HP:0004934) | 2.37171067 |
| 72 | Abnormal urine phosphate concentration (HP:0012599) | 2.37143935 |
| 73 | Peripheral hypomyelination (HP:0007182) | 2.35485684 |
| 74 | Protrusio acetabuli (HP:0003179) | 2.35471762 |
| 75 | Nephrolithiasis (HP:0000787) | 2.34148053 |
| 76 | Hyperphosphaturia (HP:0003109) | 2.34093668 |
| 77 | Pili torti (HP:0003777) | 2.33131808 |
| 78 | Ridged nail (HP:0001807) | 2.32360968 |
| 79 | Erythroderma (HP:0001019) | 2.31161469 |
| 80 | Laryngomalacia (HP:0001601) | 2.31007614 |
| 81 | Woolly hair (HP:0002224) | 2.29166615 |
| 82 | Broad face (HP:0000283) | 2.28703437 |
| 83 | Hypophosphatemia (HP:0002148) | 2.27898869 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.26311974 |
| 85 | Deep venous thrombosis (HP:0002625) | 2.25155269 |
| 86 | Ketosis (HP:0001946) | 2.24069202 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23349425 |
| 88 | Palmoplantar keratoderma (HP:0000982) | 2.20968716 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.20455258 |
| 90 | Abnormal hair laboratory examination (HP:0003328) | 2.17606305 |
| 91 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.17227043 |
| 92 | Dehydration (HP:0001944) | 2.17050032 |
| 93 | Adrenal overactivity (HP:0002717) | 2.16413471 |
| 94 | Abnormality of carpal bone ossification (HP:0006257) | 2.13427032 |
| 95 | Confusion (HP:0001289) | 2.11922671 |
| 96 | * Onion bulb formation (HP:0003383) | 2.11810493 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.11635685 |
| 98 | Cerebral aneurysm (HP:0004944) | 2.11155437 |
| 99 | Vertebral compression fractures (HP:0002953) | 2.10569317 |
| 100 | Muscle fiber splitting (HP:0003555) | 2.10011966 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 2.09788309 |
| 102 | Hypoplasia of the iris (HP:0007676) | 2.08686687 |
| 103 | Widely patent fontanelles and sutures (HP:0004492) | 2.08425636 |
| 104 | Neonatal death (HP:0003811) | 2.07244594 |
| 105 | Enlarged epiphyses (HP:0010580) | 2.06223393 |
| 106 | Abnormality of sodium homeostasis (HP:0010931) | 2.05284676 |
| 107 | Premature rupture of membranes (HP:0001788) | 2.04957464 |
| 108 | Termporal pattern (HP:0011008) | 2.04162465 |
| 109 | Insidious onset (HP:0003587) | 2.04162465 |
| 110 | Thin bony cortex (HP:0002753) | 2.02943600 |
| 111 | Stridor (HP:0010307) | 2.00046418 |
| 112 | Glomerulosclerosis (HP:0000096) | 1.99397201 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.99310384 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.98654525 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97023550 |
| 116 | Hyperparathyroidism (HP:0000843) | 1.96729072 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94771740 |
| 118 | Fragile skin (HP:0001030) | 1.93922779 |
| 119 | Obstructive sleep apnea (HP:0002870) | 1.92805225 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92589332 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 1.92589332 |
| 122 | * Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91719255 |
| 123 | Ectropion (HP:0000656) | 1.91592227 |
| 124 | Abnormality of renal resorption (HP:0011038) | 1.91031583 |
| 125 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90804530 |
| 126 | Metaphyseal cupping (HP:0003021) | 1.89658393 |
| 127 | Parakeratosis (HP:0001036) | 1.89491586 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.89383270 |
| 129 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89119641 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.88907671 |
| 131 | Cervical subluxation (HP:0003308) | 1.88618966 |
| 132 | Abnormal ossification of hand bones (HP:0005921) | 1.88355515 |
| 133 | Abnormal tarsal ossification (HP:0008369) | 1.88283765 |
| 134 | Abnormality of nucleobase metabolism (HP:0010932) | 1.88112147 |
| 135 | Ankyloglossia (HP:0010296) | 1.87868797 |
| 136 | Amyloidosis (HP:0011034) | 1.87589781 |
| 137 | Abnormality of complement system (HP:0005339) | 1.86351111 |
| 138 | Hyponatremia (HP:0002902) | 1.85522252 |
| 139 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85503390 |
| 140 | Dysostosis multiplex (HP:0000943) | 1.84532778 |
| 141 | Hypohidrosis (HP:0000966) | 1.84151254 |
| 142 | Abnormality of the costochondral junction (HP:0000919) | 1.83392342 |
| 143 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82919107 |
| 144 | Protuberant abdomen (HP:0001538) | 1.81196057 |
| 145 | Absent eyelashes (HP:0000561) | 1.80385865 |
| 146 | Gangrene (HP:0100758) | 1.80068749 |
| 147 | Complement deficiency (HP:0004431) | 1.77947760 |
| 148 | Short nail (HP:0001799) | 1.77104136 |
| 149 | Supranuclear gaze palsy (HP:0000605) | 1.77043394 |
| 150 | Hypoplasia of dental enamel (HP:0006297) | 1.76165329 |
| 151 | Distal lower limb amyotrophy (HP:0008944) | 1.76044694 |
| 152 | Sparse scalp hair (HP:0002209) | 1.75678154 |
| 153 | Decreased circulating renin level (HP:0003351) | 1.74321405 |
| 154 | Diaphragmatic weakness (HP:0009113) | 1.74204760 |
| 155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72588171 |
| 156 | Abnormality of the corticospinal tract (HP:0002492) | 1.71677895 |
| 157 | Hyperhidrosis (HP:0000975) | 1.71481841 |
| 158 | Anonychia (HP:0001798) | 1.71431294 |
| 159 | Shallow orbits (HP:0000586) | 1.71244445 |
| 160 | Potter facies (HP:0002009) | 1.70938500 |
| 161 | Facial shape deformation (HP:0011334) | 1.70938500 |
| 162 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.70937959 |
| 163 | Bronchomalacia (HP:0002780) | 1.70927197 |
| 164 | Elevated alkaline phosphatase (HP:0003155) | 1.69819585 |
| 165 | Hemorrhage of the eye (HP:0011885) | 1.69687591 |
| 166 | Popliteal pterygium (HP:0009756) | 1.68617763 |
| 167 | Sparse eyelashes (HP:0000653) | 1.67703980 |
| 168 | Metaphyseal irregularity (HP:0003025) | 1.66422419 |
| 169 | Increased connective tissue (HP:0009025) | 1.65672943 |
| 170 | Polygenic inheritance (HP:0010982) | 1.65182552 |
| 171 | Methylmalonic aciduria (HP:0012120) | 1.65038504 |
| 172 | Congenital sensorineural hearing impairment (HP:0008527) | 1.65032009 |
| 173 | Acanthosis nigricans (HP:0000956) | 1.64764251 |
| 174 | Glomerulonephritis (HP:0000099) | 1.64512748 |
| 175 | Wormian bones (HP:0002645) | 1.63319414 |
| 176 | Ventricular tachycardia (HP:0004756) | 1.62887124 |
| 177 | Arterial tortuosity (HP:0005116) | 1.62735638 |
| 178 | Distal lower limb muscle weakness (HP:0009053) | 1.62027101 |
| 179 | Renal tubular dysfunction (HP:0000124) | 1.60884087 |
| 180 | Multifactorial inheritance (HP:0001426) | 1.60645031 |
| 181 | Irritability (HP:0000737) | 1.59525013 |
| 182 | Tubular atrophy (HP:0000092) | 1.59459852 |
| 183 | Abnormal hand bone ossification (HP:0010660) | 1.59349055 |
| 184 | Ileus (HP:0002595) | 1.59300244 |
| 185 | Abolished electroretinogram (ERG) (HP:0000550) | 1.58969708 |
| 186 | Hyperkalemia (HP:0002153) | 1.58892390 |
| 187 | Focal segmental glomerulosclerosis (HP:0000097) | 1.58377170 |
| 188 | Pterygium (HP:0001059) | 1.56975579 |
| 189 | Blepharitis (HP:0000498) | 1.56300089 |
| 190 | Xanthomatosis (HP:0000991) | 1.56105300 |
| 191 | Nuclear cataract (HP:0100018) | 1.55845156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.55717546 |
| 2 | OXSR1 | 6.64622975 |
| 3 | STK39 | 6.17298541 |
| 4 | WNK3 | 5.18612324 |
| 5 | ERN1 | 3.72236061 |
| 6 | RIPK1 | 3.45502238 |
| 7 | EPHB1 | 3.17628049 |
| 8 | TRIB3 | 2.92160159 |
| 9 | WNK1 | 2.50562919 |
| 10 | PRPF4B | 2.42506203 |
| 11 | IRAK3 | 2.34969861 |
| 12 | TAOK1 | 2.02378316 |
| 13 | ARAF | 1.99432734 |
| 14 | SIK1 | 1.99322005 |
| 15 | ICK | 1.96993678 |
| 16 | PDGFRA | 1.89052240 |
| 17 | MAPKAPK5 | 1.66788073 |
| 18 | LATS2 | 1.63699960 |
| 19 | MET | 1.63366351 |
| 20 | EEF2K | 1.61742425 |
| 21 | MAP3K9 | 1.57951512 |
| 22 | TESK1 | 1.56255989 |
| 23 | PKN1 | 1.51773574 |
| 24 | MAP3K6 | 1.50286405 |
| 25 | BCKDK | 1.49673517 |
| 26 | CDK12 | 1.49430534 |
| 27 | NTRK1 | 1.43235761 |
| 28 | LMTK2 | 1.37840972 |
| 29 | SMG1 | 1.33859062 |
| 30 | MST4 | 1.28018591 |
| 31 | INSRR | 1.25845248 |
| 32 | PIM2 | 1.24455645 |
| 33 | MAPK15 | 1.23733678 |
| 34 | FGFR3 | 1.21104784 |
| 35 | CDC42BPA | 1.14345409 |
| 36 | LIMK1 | 1.12659642 |
| 37 | PKN2 | 1.09778219 |
| 38 | MAP3K2 | 1.08992882 |
| 39 | MAPKAPK3 | 1.04412704 |
| 40 | PDK2 | 1.04140163 |
| 41 | PBK | 1.02540321 |
| 42 | EPHB2 | 1.01646866 |
| 43 | FGFR2 | 1.01592197 |
| 44 | MAP2K2 | 1.00117735 |
| 45 | STK24 | 0.99623369 |
| 46 | BCR | 0.98170412 |
| 47 | PRKD3 | 0.97752126 |
| 48 | PINK1 | 0.95714951 |
| 49 | MAP2K6 | 0.92145417 |
| 50 | * SGK223 | 0.90338197 |
| 51 | * SGK494 | 0.90338197 |
| 52 | LATS1 | 0.89797967 |
| 53 | MST1R | 0.88920517 |
| 54 | UHMK1 | 0.88828918 |
| 55 | MTOR | 0.88292202 |
| 56 | CAMK2B | 0.88180889 |
| 57 | NME2 | 0.87876063 |
| 58 | IRAK2 | 0.87723110 |
| 59 | TGFBR2 | 0.86688088 |
| 60 | PAK4 | 0.84405377 |
| 61 | MOS | 0.84313408 |
| 62 | ROCK2 | 0.82359734 |
| 63 | TAOK2 | 0.79068462 |
| 64 | FER | 0.78475732 |
| 65 | PAK3 | 0.77090146 |
| 66 | KSR2 | 0.72103473 |
| 67 | LRRK2 | 0.71958832 |
| 68 | PDPK1 | 0.70233348 |
| 69 | PRKD1 | 0.69837254 |
| 70 | CAMK2D | 0.69604568 |
| 71 | PTK2 | 0.68534464 |
| 72 | CDK19 | 0.68532379 |
| 73 | CSNK1A1L | 0.68210743 |
| 74 | RIPK4 | 0.65741443 |
| 75 | MARK2 | 0.65227748 |
| 76 | STK38L | 0.61566071 |
| 77 | TTN | 0.61406973 |
| 78 | TIE1 | 0.60647569 |
| 79 | NEK6 | 0.59919665 |
| 80 | AKT3 | 0.59223994 |
| 81 | DDR2 | 0.56486482 |
| 82 | CAMK2G | 0.55974107 |
| 83 | PAK6 | 0.54937119 |
| 84 | CAMK1G | 0.54384551 |
| 85 | MAP3K1 | 0.53712159 |
| 86 | ZAP70 | 0.53670489 |
| 87 | MAP3K11 | 0.52562303 |
| 88 | PDK3 | 0.52542206 |
| 89 | PDK4 | 0.52542206 |
| 90 | FGFR4 | 0.52378949 |
| 91 | CSNK1G3 | 0.52267317 |
| 92 | STK38 | 0.50910383 |
| 93 | BRAF | 0.50861460 |
| 94 | RPS6KA2 | 0.50388684 |
| 95 | TBK1 | 0.50220225 |
| 96 | PRKCE | 0.50210835 |
| 97 | PRKCH | 0.50037604 |
| 98 | BMX | 0.49483847 |
| 99 | CDK5 | 0.48842065 |
| 100 | MAPK11 | 0.47439562 |
| 101 | PRKG2 | 0.47134410 |
| 102 | * GSK3A | 0.46625881 |
| 103 | CSNK1G1 | 0.46330163 |
| 104 | PAK2 | 0.46295099 |
| 105 | MAP3K7 | 0.45569690 |
| 106 | TYK2 | 0.45401991 |
| 107 | PTK6 | 0.45182686 |
| 108 | PRKD2 | 0.45084473 |
| 109 | EPHA3 | 0.43248674 |
| 110 | TESK2 | 0.43129249 |
| 111 | MAP3K3 | 0.43096847 |
| 112 | RET | 0.42199456 |
| 113 | JAK1 | 0.40487391 |
| 114 | DMPK | 0.39311905 |
| 115 | MAPK7 | 0.39076310 |
| 116 | DYRK1B | 0.38933655 |
| 117 | GRK1 | 0.38895612 |
| 118 | CSNK1G2 | 0.38665381 |
| 119 | HIPK2 | 0.38552277 |
| 120 | PNCK | 0.38499451 |
| 121 | SGK3 | 0.36881254 |
| 122 | PDK1 | 0.36770496 |
| 123 | STK11 | 0.35783628 |
| 124 | PDGFRB | 0.35337871 |
| 125 | FGFR1 | 0.35300523 |
| 126 | MAP2K3 | 0.35041983 |
| 127 | CAMK2A | 0.34364326 |
| 128 | IRAK1 | 0.33969170 |
| 129 | FGR | 0.32991213 |
| 130 | TRPM7 | 0.32710852 |
| 131 | ERBB2 | 0.32645823 |
| 132 | BLK | 0.32404330 |
| 133 | PRKCZ | 0.32227252 |
| 134 | PRKCQ | 0.32099219 |
| 135 | PHKG2 | 0.31991943 |
| 136 | PHKG1 | 0.31991943 |
| 137 | PTK2B | 0.31860107 |
| 138 | MUSK | 0.31002349 |
| 139 | EPHA4 | 0.30491982 |
| 140 | DAPK2 | 0.29691991 |
| 141 | TYRO3 | 0.29627503 |
| 142 | CSK | 0.29210148 |
| 143 | EPHA2 | 0.29179437 |
| 144 | FYN | 0.28274634 |
| 145 | CSNK1A1 | 0.26881095 |
| 146 | * SGK1 | 0.24881712 |
| 147 | SRC | 0.24343939 |
| 148 | PRKAA2 | 0.23143775 |
| 149 | INSR | 0.22504888 |
| 150 | ABL2 | 0.21923176 |
| 151 | MAPK12 | 0.21100845 |
| 152 | NME1 | 0.20846600 |
| 153 | CAMK1D | 0.20600162 |
| 154 | MAP3K13 | 0.20548693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.01258649 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.28018734 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.78038534 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.73534165 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39770751 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.35294680 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.35210383 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.32878246 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.30235205 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27482363 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21000571 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14675981 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.04069087 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.03952727 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.94367500 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93794599 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93268032 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86139291 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.85241454 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84002652 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68799784 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61927337 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58457780 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.58023416 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57846857 |
| 26 | Mineral absorption_Homo sapiens_hsa04978 | 1.56325740 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.51792635 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47850285 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46002945 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45014338 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40517058 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37207701 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.34468393 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33924365 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30952722 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29348689 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28858426 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.26428314 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25572489 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22191549 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20936727 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.20585999 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18692522 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.18188651 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16864220 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14050372 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.13939715 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09286631 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.08783231 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06615193 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05523562 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04097906 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99645249 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98836881 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98556611 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.96872928 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95804247 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93798786 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88818983 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88272850 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87623761 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87541603 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87025887 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86913937 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.86262493 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86234938 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85941172 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85637712 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85145931 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.83628422 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.83091594 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83076920 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82216253 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81920473 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80674636 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80317483 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78923864 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78589675 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77344448 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77314652 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77275956 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76754745 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76563554 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76411223 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75818124 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.75689876 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.75191684 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75013780 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74860854 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74643284 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74582477 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74294013 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69693584 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.69488542 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69040875 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67317327 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.66915482 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66537647 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66191550 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65633395 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65484292 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65180685 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65135693 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65095455 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64397109 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63543371 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63427463 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62263176 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61709078 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61419133 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61017933 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60936239 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60524548 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.60330233 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59981504 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59502414 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58791014 |
| 118 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58300797 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58100167 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57057214 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55312820 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55114699 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54631503 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53984242 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53884183 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53437791 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53379090 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.52694760 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.52264174 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52163879 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51533137 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51306658 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50580360 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50061669 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49398177 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45812181 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45360215 |
| 138 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43786799 |
| 139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40278692 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40009010 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39908998 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38797044 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36858552 |
| 144 | Axon guidance_Homo sapiens_hsa04360 | 0.36231027 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35199915 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35005515 |
| 147 | Salivary secretion_Homo sapiens_hsa04970 | 0.34817487 |
| 148 | ABC transporters_Homo sapiens_hsa02010 | 0.34730731 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33518849 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.33402422 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32743611 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31978285 |
| 153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31552158 |
| 154 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31326584 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29775304 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29144526 |
| 157 | Insulin secretion_Homo sapiens_hsa04911 | 0.29048694 |
| 158 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27254835 |
| 159 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26305925 |
| 160 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.25944032 |
| 161 | Phagosome_Homo sapiens_hsa04145 | 0.24109177 |
| 162 | Protein export_Homo sapiens_hsa03060 | 0.24004384 |
| 163 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23003569 |

